Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
103.82
+6.91 (7.13%)
At close: May 12, 2025, 4:00 PM
103.21
-0.61 (-0.59%)
After-hours: May 12, 2025, 7:58 PM EDT
Gilead Sciences Employees
Gilead Sciences had 17,600 employees as of December 31, 2024. The number of employees decreased by 400 or -2.22% compared to the previous year.
Employees
17,600
Change (1Y)
-400
Growth (1Y)
-2.22%
Revenue / Employee
$1,632,670
Profits / Employee
$338,920
Market Cap
129.14B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GILD News
- 8 hours ago - Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet - Seeking Alpha
- 5 days ago - Gilead announces $11 billion in new investments in US - Reuters
- 5 days ago - Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment - Business Wire
- 5 days ago - Gilead's Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of Prior Treatment History in New Data Presented at EASL 2025 - Business Wire
- 13 days ago - Gilead Sciences to Present at Upcoming Investor Conferences - Business Wire
- 13 days ago - Gilead Sciences reaches $202 million settlement with US over kickbacks to doctors - Reuters
- 13 days ago - Gilead Sciences agrees to pay $202 million to settle claims of kickbacks to doctors for HIV drug prescriptions - CNBC
- 13 days ago - Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis - Business Wire